Benzoic acid & Salicylic acid ointment

Benzoic acid & Salicylic acid ointment
Product Description

Compound Benzoic acid & Salicylic acid Ointment is a compound preparation of benzoic acid and salicylic acid, mixed in 2:1 ratio to make a ointment. Benzoic acid in this product has the effect of inhibiting fungi, but the anti-bacterial effect is weak; Salicylic acid has the effect of inhibiting fungi and bacteria, has the effect of keratolytic, can make the epidermis loose and fall off, and has the effect of relieving itching. In the treatment of superficial mycosis, the killed or inhibited mold is shed and removed with the peeling of the epidermis. High concentration of salicylic acid has corrosive effect, so it is compatible with benzoic acid to avoid the corrosive effect of salicylic acid.

Liaoning Huarui Union Pharmaceutical Co., Ltd

  • CN
  • 2024
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Biopharmaceutical company
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Biopharmaceutical
Contract Manufacturer
Pharmaceutical Company (generic finished products)
Specifications
  • Details
    Benzoic acid: 6%;Salicylic acid: 3%;
  • Selling Points
    Place of Origin; Price; Quality Service
  • Model
    20g
  • Supplied from
    China
  • Measured In
    gram

Liaoning Huarui Union Pharmaceutical Co., Ltd

  • CN
  • 2024
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Biopharmaceutical company
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Biopharmaceutical
Contract Manufacturer
Pharmaceutical Company (generic finished products)

More Products from Liaoning Huarui Union Pharmaceutical Co., Ltd (4)

  • Ciprofloxacin Tablets

    Product Ciprofloxacin Tablets

    Ciproflooxacin exhibits potent bacterial action by interfering with enzyme DNA gyrase which is needed for the synthesis of bacterial DNA. The in vitro antimicrobial spectrum of Ciprofloxacin includes wide range of microorganisms including the most Gram-negative bacteria and Gram-positive bacteria. Most str...
  • Cotrimoxazole for oral Suspension

    Product Cotrimoxazole for oral Suspension

    Cotrimoxazole for oral suspension is a sulfanilamide antimicrobial drug, which is a combination of sulfamethoxazole (SMZ) and trimethoprim (TMP). It has good antibacterial effect on non-enzymatic Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, Escherichia coli, Klebsiella, Salmonel...
  • Omeprazole Capsules 20mg

    Product Omeprazole Capsules 20mg

    Omeprazole is a proton-pump inhibitor, used to treat gastric acid-related disorders. These disorders may include gastroesophageal reflux disease (GERD), peptic ulcer disease, and other diseases characterized by the oversecretion of gastric acid. This drug was the first clinical useful drug in its class. Om...
  • Omeprazole Sodium Injection

    Product Omeprazole Sodium Injection

    Omeprazole Sodium Injection is an alternative treatment for the following conditions when oral therapy is not appropriate: duodenal ulcer, gastric ulcer, reflux esophagitis and Zollinger-Ellison syndrome.Administration:
    1. Intravenous drip.
    2. Dissolve the contents of the bottle in 100ml 0.9% sodiu...

Liaoning Huarui Union Pharmaceutical Co., Ltd resources (1)

  • Brochure Liaoning Huarui Union Pharmaceutical Co., Ltd. Introduction

    Liaoning Huarui Union Pharmaceutical Co., Ltd., founded in 1987, was originally subordinate to "Northeast Pharmaceutical Group". The company is located in Dandong, the largest border city in China, with superior environment and convenient transportation. The company covers an area of 36000 square meters and a construction area of 14700 square meters. The company has an independent R & D laboratory and five workshops for ordinary solid preparations, cephalosporin solid preparations, cream tincture water agent raw materials and traditional Chinese medicine extraction, with an annual production of 3 billion tablets, 4 billion capsules and 100 million bags of granules,50 million pieces of ointment. It passed the new version of GMP inspection in China in June 2015.After more than 10 years of continuous accumulation and innovation, Liaoning Huarui Union Pharmaceutical Co., Ltd. has formed a large-scale backbone enterprise.